mcc

Printed by hongbin zhang on 12/23/2012 4:23:22 AM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
NCCN Guidelines™ Version 1.2012 Panel Members Merkel Cell Carcinoma
* Stanley J. Miller, MD/Chair v ¶ z The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Murad Alam, MD v ¶ z Robert H. Lurie Comprehensive Cancer Center of Northwestern University James Andersen, MD ¶ City of Hope Comprehensive Cancer Center Daniel Berg, MD v Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Christopher K. Bichakjian, MD v University of Michigan Comprehensive Cancer Center Glen Bowen, MD v Huntsman Cancer Institute at the University of Utah Richard T. Cheney, MD ¹ Roswell Park Cancer Institute L. Frank Glass, MD v ¹ H. Lee Moffitt Cancer Center & Research Institute
Clinical Trials: The NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged. To find clinical trials online at NCCN member institutions, click here: /clinical_trials/physician.html
NCCN Guidelines Index Merkel Cell Carcinoma TOC Discussion
Roy C. Grekin, MD v ¶ UCSF Helen Diller Family Comprehensive Cancer Center Alan L. Ho, MD, PhD † Memorial Sloan-Kettering Cancer Center Anne Kessinger, MD † UNMC Eppley Cancer Center at The Nebraska Medical Center Nanette Liegeois, MD, PhD v ¶ z The Sidney Kimmelopkins Daniel D. Lydiatt, DDS, MD ¶ z UNMC Eppley Cancer Center at The Nebraska Medical Center Jeff Michalski, MD, MBA § Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine William H. Morrison, MD § The University of Texas MD Anderson Cancer Center Kishwer S. Nehal, MD v ¶ Memorial Sloan-Kettering Cancer Center
NCCN Guidelines Index Merkel Cell Carcinoma TOC Discussion
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™)
Merkel Cell Carcinoma
Version 1.2012
v Dermatology ¶ Surgery/Surgical oncology z Otolaryngology ¹ Pathology/Dermatopathology † Medical oncology § Radiotherapy/Radiation oncology ‡ Hematology/Hematology oncology * Writing Committee Member
NCCN Categories of Evidence and
Consensus: All recommendations are Category 2A unless otherwise specified. See NCCN Categories of Evidence and Consensus
Merkel Cell Carcinoma Clinical Presentation, Preliminary Workup, and Clinical Findings (MCC-1) Primary Treatment of Clinical N0 (MCC-2) Primary Treatment of Clinical N+ (MCC-3) Treatment of Clinical M1(MCC-4) Follow-up and Recurrence (MCC-5) Principles of Radiation Therapy (MCC-A) Principles of Excision (MCC-B) Chemotherapy Agents (MCC-C)
Kelly C. Nelson, MD ¹ Duke Cancer Institute Paul Nghiem, MD, PhD v Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Thomas Olencki, DO † The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Clifford S. Perlis, MD, MBe v ¶ Fox Chase Cancer Center Ashok R. Shaha, MD ¶ z Memorial Sloan-Kettering Cancer Center Malika Tuli, MD v St. Jude Children’s Research Hospital/ University of Tennessee Cancer Institute Marshall M. Urist, MD ¶ University of Alabama at Birmingham Comprehensive Cancer Center Linda C. Wang, MD, JD v Dana-Farber/Brigham and Women’s Cancer Center John A. Zic, MD v Vanderbilt-Ingram Cancer Center NCCN Lauren Gallagher, RPh, PhD Maria Ho, PhD Nicole McMillian, MS NCCN Guidelines Panel Disclosures
Staging (ST-1)
The NCCN Guidelines™ are a statement of evidence and consensus of the authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult the NCCN Guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient’s care or treatment. The National Comprehensive Cancer Network® (NCCN®) makes no representations or warranties of any kind regarding their content, use or application and disclaims any responsibility for their application or use in any way. The NCCN Guidelines are copyrighted by National Comprehensive Cancer Network®. All rights reserved. The NCCN Guidelines and the illustrations herein may not be reproduced in any form without the express written permission of NCCN. ©2011.
Printed by hongbin zhang on 12/23/2012 4:23:22 AM. For personal use only. Not approved for distribution. Copyright © 2012 National Comprehensive Cancer Network, Inc., All Rights Reserved.
Continue
Version 1.2012, 09/27/11 © National Comprehensive Cancer Network, Inc. 2011, All rights reserved. The NCCN Guidelines™ and this illustration may not be reproduced in any form without the express written permission of NCCN®.
NCCN Guidelines™ Version 1.2012 Table of Contents Merkel Cell Carcinoma
NCCN Merkel Cell Carcinoma Panel Members Summary of the Guidelines Updates
NCCN Guidelines Index Merkel Cell Carcinoma TOC Discussion
Continue
Version 1.2012, 09/27/11 © National Comprehensive Cancer Network, Inc. 2011, All rights reserved. The NCCN Guidelines™ and this illustration may not be reproduced in any form without the express written permission of NCCN®.